CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Astellas Pharma Inc (Parent) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Astellas Pharma Inc (Parent)
2-5-1, Nihombashihon-cho
Phone: +81 332443000p:+81 332443000 CHUO-KU, TKY  103-8411  Japan

Business Summary
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/20083/31/2008Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chairman of the Board of Directors, Representative Director KenjiYasukawa 61 4/1/2023 6/19/2017
President, Chief Executive Officer, Representative Director NaokiOkamura 60 4/1/2023 6/1/2016
Vice President, Chief People Officer, Chief Ethics & Compliance Officer, Representative Director KatsuyoshiSugita 55 6/22/2023 10/1/2022
8 additional Officers and Directors records available in full report.

Business Names
Business Name
4503
Agensys, Inc.
ALPMY
40 additional Business Names available in full report.

General Information
Number of Employees: 5,419 (As of 3/31/2008)
Outstanding Shares: 1,796,617,995 (As of 3/29/2023)


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023